Atypical presentation of patients with chronic myeloid leukemia in chronic phase-Case report.

BCR-ABL + atypical transcripts chronic myedoid leukemia (CML) e6a2 outcome tyrosine kinase inhibitors

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 03 06 2022
accepted: 28 07 2022
entrez: 15 9 2022
pubmed: 16 9 2022
medline: 16 9 2022
Statut: epublish

Résumé

The presence of the translocation t(9;22)(q34;q11), leading to the

Identifiants

pubmed: 36106102
doi: 10.3389/fonc.2022.960914
pmc: PMC9464917
doi:

Types de publication

Case Reports

Langues

eng

Pagination

960914

Informations de copyright

Copyright © 2022 Ramdohr, Fabarius, Maier, Bretschneider, Jauch, Monecke, Metzeler, Janssen, Schlenk and Kayser.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cells. 2020 Jul 08;9(7):
pubmed: 32650416
Int J Lab Hematol. 2017 Jun;39(3):235-242
pubmed: 28035733
In Vivo. 2020 May-Jun;34(3):1481-1486
pubmed: 32354950
Nature. 1973 Jun 1;243(5405):290-3
pubmed: 4126434
Blood. 1996 Sep 15;88(6):2236-40
pubmed: 8822944
Anticancer Res. 2019 Jul;39(7):3949-3954
pubmed: 31262926
Int J Hematol. 2009 Sep;90(2):230-234
pubmed: 19565180
Leuk Lymphoma. 2007 May;48(5):1034-7
pubmed: 17487751
J Natl Cancer Inst. 1960 Jul;25:85-109
pubmed: 14427847
Blood Cancer J. 2017 Jul 14;7(7):e583
pubmed: 28708130
Nat Genet. 2013 Oct;45(10):1232-7
pubmed: 23955599
Leukemia. 2005 Nov;19(11):1991-2
pubmed: 16151468
Am J Blood Res. 2020 Apr 15;10(2):22-25
pubmed: 32411499
Acta Haematol. 2009;122(1):11-6
pubmed: 19641300
Leuk Lymphoma. 2019 Dec;60(12):3051-3057
pubmed: 31258010
Leukemia. 2008 Apr;22(4):856-8
pubmed: 17851552
Onco Targets Ther. 2021 Apr 12;14:2497-2503
pubmed: 33883904
Ann Hematol. 2011 Oct;90(10):1241-3
pubmed: 21302112
Sci Rep. 2015 Oct 06;5:14829
pubmed: 26439403
Br J Haematol. 2000 Jun;109(3):635-7
pubmed: 10886215
Cancer Genet. 2019 Sep;237:78-81
pubmed: 31447069
Leukemia. 2015 May;29(5):999-1003
pubmed: 25652737
Leukemia. 2003 Oct;17(10):2054-5
pubmed: 14513059
Mol Med Rep. 2016 Mar;13(3):2635-8
pubmed: 26847385
Haematologica. 2022 Apr 07;:
pubmed: 35385922
Ecancermedicalscience. 2021 Apr 22;15:1221
pubmed: 34158825
Leuk Lymphoma. 2021 Sep;62(9):2064-2078
pubmed: 33944660
Nature. 1985 Jun 13-19;315(6020):550-4
pubmed: 2989692
Med Oncol. 2013 Jun;30(2):508
pubmed: 23430446

Auteurs

Florian Ramdohr (F)

Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.

Alice Fabarius (A)

Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.

Bettina Maier (B)

Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.

Daniela Bretschneider (D)

Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.

Anna Jauch (A)

Institute of Human Genetics, University Heidelberg, Heidelberg, Germany.

Astrid Monecke (A)

Department of Diagnostics, Institute of Pathology, University Hospital Leipzig, Leipzig, Germany.

Klaus H Metzeler (KH)

Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.

Johannes W G Janssen (JWG)

Institute of Human Genetics, University Heidelberg, Heidelberg, Germany.

Richard F Schlenk (RF)

Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Department of Medical Oncology, National Center of Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany.

Sabine Kayser (S)

Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.
NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Classifications MeSH